CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-10-02 | Biller Scott Chief Scientific Officer | Sale | −955 | $67.23 | $64K | 6,264 |
| 2017-10-02 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −1,191 | 34,090 | ||
| 2017-10-02 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −955 | 34,331 | ||
| 2017-10-02 | Schenkein David P Chief Executive Officer | Option exercise | +6,000 | $0.30 | $2K | 6,000 |
| 2017-10-02 | Schenkein David P Chief Executive Officer | Sale | −6,000 | $66.76 | $401K | 0 |
| 2017-10-02 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −6,000 | 112,656 | ||
| 2017-09-18 | Schenkein David P Chief Executive Officer | Option exercise | +35,000 | $0.30 | $11K | 35,000 |
| 2017-09-18 | Schenkein David P Chief Executive Officer | Sale | −35,000 | $67.12 | $2.3M | 0 |
| 2017-09-18 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −35,000 | 118,656 | ||
| 2017-09-14 | Cantley Lewis Clayton Jr. Director | Sale | −1,000 | $65.71 | $66K | 85,394 |
| 2017-09-14 | Cantley Lewis Clayton Jr. Director | Sale | −1,000 | $65.71 | $66K | 85,434 |
| 2017-09-13 | Cantley Lewis Clayton Jr. Director | Sale | −1,000 | $65.47 | $65K | 86,394 |
| 2017-09-13 | Cantley Lewis Clayton Jr. Director | Sale | −1,000 | $65.47 | $65K | 86,434 |
| 2017-09-11 | Bowden Christopher Chief Medical Officer | Option exercise | +6,000 | $35.16 | $211K | 6,881 |
| 2017-09-11 | Bowden Christopher Chief Medical Officer | Sale | −6,000 | $65.00 | $390K | 881 |
| 2017-09-11 | Bowden Christopher Chief Medical Officer | Option exercise · Stock option (right to buy) | −6,000 | 109,000 | ||
| 2017-09-11 | Biller Scott Chief Scientific Officer | Sale | −15,000 | $65.00 | $975K | 10,470 |
| 2017-09-07 | Schenkein David P Chief Executive Officer | Gift | −500 | 271,772 | ||
| 2017-09-01 | Biller Scott Chief Scientific Officer | Option exercise | +2,146 | $9.05 | $19K | 8,410 |
| 2017-09-01 | Biller Scott Chief Scientific Officer | Sale | −2,146 | $61.99 | $133K | 6,264 |
Page 72 of 80 · 1,590 trades